Select Date
Select Date
2026-10 10
STO-609 inhibitor targeted CaMKKβ blockade attenuates M1R-stimulated AMPK signaling and neurite extension
STO-609 inhibitor targeted CaMKKβ blockade attenuates M1R-stimulated AMPK signaling and neurite extension
AZD0156 inhibits ATM kinase to promote selective radiosensitization in human melanoma cells
AZD0156 inhibits ATM kinase to promote selective radiosensitization in human melanoma cells
GS-5734 (Remdesivir) GS-5734 Target RdRp Polymerase Inhibition in Viral Replication
GS-5734 (Remdesivir) GS-5734 Target RdRp Polymerase Inhibition in Viral Replication
V-9302 Amino acid transport antagonist Target Engagement in SLC1A5-Mediated Uveal Melanoma Therapy
V-9302 Amino acid transport antagonist Target Engagement in SLC1A5-Mediated Uveal Melanoma Therapy
LY110140 (Fluoxetine Hydrochloride) Restores Antitumor Immunity and Prevents Stress-Induced Lymphoma Dissemination
LY110140 (Fluoxetine Hydrochloride) Restores Antitumor Immunity and Prevents Stress-Induced Lymphoma Dissemination
CB-5083 ATPase inhibitor targets p97 D2 domain to induce proteotoxic stress and apoptosis
CB-5083 ATPase inhibitor targets p97 D2 domain to induce proteotoxic stress and apoptosis
ARN-509 (Apalutamide) Inhibition of Androgen Receptor Translocation and Transcription in Prostate Cancer
ARN-509 (Apalutamide) Inhibition of Androgen Receptor Translocation and Transcription in Prostate Cancer
Tetrathiomolybdate (TM) Modulates Tumor Microenvironment Dynamics and Intratumoral Bacterial Metabolism to Overcome Resistance
Tetrathiomolybdate (TM) Modulates Tumor Microenvironment Dynamics and Intratumoral Bacterial Metabolism to Overcome Resistance
Zanubrutinib (BGB-3111) BGB3111 BTK Inhibitor Multiplex LC-MS/MS Plasma Quantification Assay
Zanubrutinib (BGB-3111) BGB3111 BTK Inhibitor Multiplex LC-MS/MS Plasma Quantification Assay
LOXO-292 (Selpercatinib) LOXO292 Targeted RET Kinase Inhibition in Solid Tumors
LOXO-292 (Selpercatinib) LOXO292 Targeted RET Kinase Inhibition in Solid Tumors